Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

PD-L1 expression + HER-2 overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

PD-L1 expression + HER-2 overexpression	Gastroesophageal Junction Adenocarcinoma	PD-L1 expression + HER-2 overexpression	Gastroesophageal Junction Adenocarcinoma	pembrolizumab + margetuximab-cmkb Sensitive: C3 – Early Trials pembrolizumab + margetuximab-cmkb Sensitive : C3	pembrolizumab + margetuximab-cmkb Sensitive: C3 – Early Trials pembrolizumab + margetuximab-cmkb Sensitive : C3
PD-L1 expression + HER-2 overexpression	Gastric Cancer	PD-L1 expression + HER-2 overexpression	Gastric Cancer	pembrolizumab + margetuximab-cmkb Sensitive: C3 – Early Trials pembrolizumab + margetuximab-cmkb Sensitive : C3	pembrolizumab + margetuximab-cmkb Sensitive: C3 – Early Trials pembrolizumab + margetuximab-cmkb Sensitive : C3